3 Growing Stocks That Can Make You Rich In March - Vertex Medical Products

 

2 - Vertex Medical Products

The vast majority of Biotechnology stocks have been losing money recently. Companies will struggle to break that drastically with a drug that will shake the market. Private drug developer Vertex Pharmaceuticals (NASDAQ: VRTX) is one of the companies that make this look easy. What makes Vertex such a great company is its success in developing treatments for Cystic Fibrosis (CF). Cystic Fibrosis is a chronic disease that can block the pancreas and lungs (many places in the body) with a thick layer of mucus. There is no cure, but Vertex helps to improve the quality of life of CF patients with its solutions. The company's newest treatment is the combination therapy Trikafta, which is permitted by the U.S. Food and Drug Administration about five months before the review date. Trikafta achieved net sales of approximately $ 3.9 billion in its first year on the pharmacy shelves. It looks like it will exceed $ 6 billion by the end of the year. Developing multiple CF therapies needs a long-term protection of the company's cash flow. With Vertex sitting on $ 6.66 billion in cash at the end of 2020, Vertex is in an excellent position to invest, given that it will diversify its product portfolio beyond KF. It is not surprising if the total growth of Vertex remains above 10 percent for a long time.   3 Growing Stocks That Can Make You Rich In March - Vertex Medical Products Source: https://www.fool.com/ You may also be interested in:

3 Growing Stocks That Can Make You Rich In March - Zoom Video Communications